未登录

P

Pere Fontova

hospital universitari de bellvitge-idibell

H指数:11

被引数:519

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study

优化肾移植受者中IR-Tac至LCP-Tac制剂的剂量转换：一项群体药代动力学模型研究

Pharmaceutics 2025, Vol. 17, Page 1185

IF5.5

2025-09-190

OAAI

Deregulation of lactate permeability using a small-molecule transporter (Lactrans-1) disturbs intracellular pH and triggers cancer cell death

使用小分子转运蛋白 (Lactrans-1) 的乳酸通透性失调会干扰细胞内pH并引发癌细胞死亡

BIOCHEMICAL PHARMACOLOGY

IF5.6

2024-11-012

OAAI

Elucidating molecular differences between cytoprotective and cytotoxic autophagy in lung cancer cell models

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-010

PRE

Disrupting ion homeostasis of specific cellular organelles as a new therapeutic strategy for cancer treatment

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-010

PRE

CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

IF5.5

2023-11-293

OAAI

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

KIDNEY INTERNATIONAL

IF12.6

2023-10-0110

OAAI

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

IF5.5

2023-05-125

OAAI

Cytotoxicity of osmium(ii) and cycloosmated half-sandwich complexes from 1-pyrenyl-containing phosphane ligands

DALTON TRANSACTIONS

IF3.3

2023-01-013

OA

Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma

IF5.5

2022-12-286

OAAI

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-06-271

OAAI

The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2021-06-0113

OAAI

Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2021-03-256

PREAI

Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-03-1024

OAAI

Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-02-014

OAAI

Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS

CLINICA CHIMICA ACTA

IF2.9

2020-04-016

OAAI

Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring)

CLINICA CHIMICA ACTA

IF2.9

2019-08-017

PREAI

Extended Release Tacrolimus (LCP-TAC) Prolongs Calcineurin Activity Inhibition During Drug Doses Intervals

TRANSPLANTATION

IF5

2018-07-011

PREAI

PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2018-02-1224

PREAI

TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells

IF4.2

2017-09-10139

OAAI